Researchers show prebiotic can reduce severity of colitis

Researchers at Michigan State University have shown a prebiotic may help the body's own natural killer cells fight bacterial infection and reduce inflammation, greatly decreasing the risk of colon cancer.

Prebiotics are fiber supplements that serve as food for the trillions of tiny bacteria living in the gut. When taken, they can stimulate the growth of the "good" bacteria. The evolution of supplements (as well as , which are actual bacteria ingested into the system) provide new therapeutic targets for researchers and physicians.

In research published in the Journal of Nutrition, MSU's Jenifer Fenton reports that mice given the prebiotic galacto-oligosaccharide, or GOS, saw the severity of their colitis (one of the main forms of ) significantly reduced.

In fact, the mice fed GOS – a synthetic compound that is known to stimulate beneficial bacteria and is found in foods such as biscuits and infant formula – saw a 50 percent reduction in colitis.

Research has shown certain types of foods and fibers can reduce risk, said Fenton of the Department of Food Science and Human Nutrition.

"There is something unique about certain types of fibers, such as GOS, and how they alter cells and influence the to change disease risk, either for the good or bad," she said. "Our overall goal is to identify either dietary patterns or diet components to reduce inflammation and cancer risk.

"In this case, we used prebiotics to stimulate changes in bacteria in the gut that may have a beneficial impact on the colon."

Fenton worked closely on the project with Elizabeth Gardner, also with the Department of Food Science and Human Nutrition and who previously has looked at the impact diet plays in fighting off the flu. In applying some of the lessons learned in those studies to mice with bacterially induced colitis, the researchers found mice given GOS had significantly less inflammation and fewer abnormal cells, two precursors for colon cancer.

It appeared, Fenton said, the positive results were linked to the significant enhancement of the body's own , found in the immune system and crucial in fighting off new infections in the body.

"Our results suggest GOS may be effective in reducing colitis severity by priming the innate immune system," she said.

The next step is to verify how that mechanism works; finding that link could help researchers apply the lessons learned to other intestinal ailments.

Related Stories

Low-calorie diet may be harmful for bowel disease patients

Mar 20, 2012

In a surprising result, Michigan State University researchers looking at the effects of diet on bowel disease found that mice on a calorie-restricted diet were more likely to die after being infected with an inflammation-causing ...

Fish oil linked to increased risk of colon cancer in mice

Oct 05, 2010

Fish oil – long encouraged by doctors as a supplement to support heart and joint health, among other benefits – induced severe colitis and colon cancer in mice in research led by Michigan State University and published ...

Prebiotic potential of almonds

Jun 27, 2008

Almonds, as well as being high in vitamin E and other minerals, are also thought to have other health benefits, such as reducing cholesterol. Recently published work by the Institute of Food Research has identified potential ...

Prebiotic potential of almonds

Jun 27, 2008

Almonds, as well as being high in vitamin E and other minerals, are also thought to have other health benefits, such as reducing cholesterol. Recently published work by the Institute of Food Research has ...

Immune sensors suppress colitis-associated cancer

Apr 12, 2010

Particular components of inflammasomes -- protein complexes needed for generating immune responses to pathogens and cellular damage—lessen the severity of colitis and colitis-associated colon cancer in mice, according to ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

10 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.